Novo Nordisk stated that the Wegovy pill will be available in January 2026
Are there tests to measure GLP-1 levels
What Happened in Court The case has gone through multiple stages: A federal judge initially dismissed Lillys first complaint , finding it hadnt sufficiently shown how Lilly was harmed
Colonic mRNA expression analysis in Glp1r / mice at baseline reveal significant reductions in trefoil factor ( Tff-1 and -2), transforming growth factor ( Tgf-b1 and Tgf-3 ), epidermal growth factor receptor ( Egfr ), keratinocyte growth factor ( Fgf7 ), hepatocyte growth factor ( Hgf ) (epithelial protection and repair), Il6, Il1b (innate immune response), Il12b (inflammation) (Yusta et al., 2015)
These include but are likely not limited to chronic hyperglycemia, hypertension, dyslipidemia, obesity, insulin resistance, sodium retention, neurohormonal activation and low-grade inflammation, all related to the metabolic syndrome [9, 10]
CagriSema appears closest to a possible approval given its reported regulatory submission, while retatrutide leads on reported efficacy